Saemundur 'Sam' Oddsson, Sidekick Health co-founder and CMO

Pfiz­er teams up with dig­i­tal ther­a­peu­tics part­ner for next prod­uct launch, this time in atopic der­mati­tis

Big Phar­ma has been slow­ly but sure­ly warm­ing up to the po­ten­tial of dig­i­tal ther­a­peu­tics, as ev­i­denced by Sanofi ink­ing a deal two months ago with Dar­i­o­Health. And on Thurs­day, an­oth­er Big Phar­ma will take a look at the space in what it deems as sim­ply the next step in an on­go­ing part­ner­ship.

Ice­landic biotech Side­kick Health an­nounced the launch of its dig­i­tal ther­a­peu­tics prod­uct specif­i­cal­ly geared for atopic der­mati­tis Thurs­day along­side Pfiz­er, its Big Phar­ma part­ner who col­lab­o­rat­ed on the in­di­ca­tion. CMO and co-founder Sae­mu­ndur “Sam” Odd­s­son told End­points News that this is not the first time that Pfiz­er and Side­kick Health have worked to­geth­er — in fact, it is the fourth dig­i­tal ther­a­peu­tics prod­uct that the pair have co-launched.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.